Skip to main content
TipRanks
Go Ultimate75% OFF

Seelos Therapeutics (SEELQ) Stock Price & Analysis

1,199 Followers

SEELQ Stock Chart & Stats

$0.00$0.00(0.00%)
At close: 3:06 PM EDT
$0.17$0.175$0.18$0.185Jul 20Aug 3Aug 17Aug 31Sep 14Sep 28Oct 12
Day’s Range
$0.18 - $0.18
52-Week Range
$0.18 - $0.18
Previous Close
$0.18
Volume
N/A
Average Volume (3M)
423
Market Cap
$1
Enterprise Value
$11.36T
Total Cash (Recent Filing)
N/A
Total Debt (Recent Filing)
$147.00K
Price to Earnings (P/E)
―
Beta
-25.17
Next Earnings
N/A
EPS Estimate
N/A
Next Dividend Ex-Date
N/A
Dividend Yield
N/A

Bulls Say, Bears Say

Bulls Say

Pipeline Potential

Seelos' focus on CNS disorders and rare diseases positions it well in niche markets with high unmet needs, potentially leading to successful drug approvals and partnerships.

Revenue Generation Strategy

The company's strategy to generate revenue through strategic partnerships and licensing agreements can provide financial support and enhance its R&D capabilities.

Gross Profit Margin

A 100% gross profit margin indicates effective cost management in its operations, which is crucial for sustaining profitability once products are commercialized.

Bears Say

Negative Stockholders' Equity

Negative equity suggests liabilities exceed assets, posing solvency risks and necessitating financial restructuring to ensure long-term viability.

Cash Flow Challenges

Ongoing negative cash flow indicates persistent cash outflows, which could threaten sustainability without new financing or successful product commercialization.

Operational Losses

Significant operational losses highlight inefficiencies and the need for cost management improvements to achieve profitability and long-term growth.

SEELQ FAQ

What was Seelos Therapeutics’s price range in the past 12 months?
Seelos Therapeutics lowest stock price was $0.18 and its highest was $0.18 in the past 12 months.
What is Seelos Therapeutics’s market cap?
Seelos Therapeutics’s market cap is $1.
When is Seelos Therapeutics’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Seelos Therapeutics’s earnings last quarter?
Seelos Therapeutics released its earnings results on Aug 02, 2024. The company reported $0.124 earnings per share for the quarter.
Is Seelos Therapeutics overvalued?
Not enough analysts have published a price target to calculate whether the price is overvalued.
Does Seelos Therapeutics pay dividends?
Seelos Therapeutics does not currently pay dividends.
What is Seelos Therapeutics’s EPS estimate?
Seelos Therapeutics’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Seelos Therapeutics have?
Seelos Therapeutics has 1,362,880 shares outstanding.
What happened to Seelos Therapeutics’s price movement after its last earnings report?
Seelos Therapeutics reported an EPS of $0.124 in its last earnings report. Following the earnings report the stock price went down -20%.
Which hedge fund is a major shareholder of Seelos Therapeutics?
Hedge funds hold Seelos Therapeutics shares: the largest hedge-fund position in Seelos Therapeutics is 71,857,092 shares, and hedge funds decreased their holdings by 354.0 shares last quarter.
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology